首頁 > 市場調查報告書 > 製藥

神經疾病

市場調查報告書

商品編碼

1536677

輕度認知障礙市場，按適應症、按疾病類型、按年齡層、按國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Mild Cognitive Impairment Market, By Indication, By Disease Type, By Age Group, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: 2024年08月04日 | 出版商:

AnalystView Market Insights | 英文 311 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

報告要點

2023 年，輕度認知障礙市場規模為 1,98,021 萬美元，2024 年至 2032 年複合年成長率為 5.24%。

輕度認知障礙市場-市場動態

人口老化和診斷方法的進步預計將推動市場需求

隨著人口的增加，MCI 和其他認知障礙的盛行率也會增加。越來越多的舊燃料需要診斷工具、處理方法和管理策略。醫療保健提供者和公眾對 MCI 有了更高的認知和理解。診斷方法的進步和教育力度的加強有助於提高檢出率和隨後對介入措施的需求。

此外，認知健康及相關領域醫療保健支出的增加推動了 MCI 相關產品和服務的需求。政府和私營部門正在投資更好的認知障礙護理解決方案。認知訓練應用程式、遠距醫療和穿戴式裝置等數位健康技術的興起增強了 MCI 的管理和監控。科技提高了患者的參與度，並為治療和研究提供了新的途徑。旨在控制症狀或改變 MCI 進展的藥物的開發會影響市場動態。新的治療藥物和臨床試驗有助於製藥業的成長。

輕度認知障礙市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 524% 左右的複合年成長率成長

根據適應症細分，由於阿茲海默症病例增加，預計阿茲海默症 (AD) 細分市場將在 2023 年顯示最大的市場佔有率。

根據疾病類型細分，由於老年人中的盛行率較高，遺忘症部分將成為 2023 年的主要疾病類型。

根據年齡層細分，由於對阿茲海默症、血管性失智症等治療的需求量很大，2023年老年病是領先的年齡層。

從地區來看，北美是 2023 年的主要收入來源，主要是由於阿茲海默症的高發生率。

輕度認知障礙市場-細分分析：

全球輕度認知障礙市場根據適應症、疾病類型、年齡層和地區進行細分。

根據適應症，市場分為五類：阿茲海默症、血管性失智症、路易氏體失智症、巴金森氏症失智症等。阿茲海默症癡呆細分市場佔據主導地位。失智症的治療需要輕度認知障礙，這有助於細分市場的成長。

根據疾病類型，市場分為兩類：遺忘性 MCI 和非遺忘性 MCI。記憶刪除 MCI 領域預計將佔據最大的市場佔有率。遺忘症輕度認知障礙表示記憶力不足，病情並不嚴重，但在老年人中越來越多。

市場依年齡層分為三類：兒童、成人和老年人。老年醫學領域在市場中佔據主導地位，預計在預測期內將保持其高度主導地位。患有阿茲海默症和輕度認知障礙問題的老年人正在推動細分市場的需求。

輕度認知障礙市場 - 地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。北美在輕度認知障礙市場中佔據主導地位。美國老年人口數量龐大且不斷成長，導致 MCI 盛行率較高。在研發方面進行了大量投資，並擁有支援早期診斷和治療的先進醫療基礎設施。在亞洲，日本的老年人比例很高，並且在認知障礙相關的研究和開發方面處於領先地位。該國擁有完善的管理 MCI 的醫療保健服務。

輕度認知障礙市場-競爭格局：

輕度認知障礙市場競爭中等。市場上的公司致力於開發旨在管理 MCI 和相關認知障礙的藥物和療法。 Biogen 和 Eli Lily 等公司正在開發阿茲海默症和其他可能與 MCI 重疊的神經退化性疾病的治療方法。擁有強大研發管道的公司對於推進治療和診斷至關重要。生物標記和藥物開發的創新是關鍵的競爭因素。

介紹
- 按地理位置分類的細分市場佔有率分析
北美洲
- 概述
- 北美輕度認知障礙主要製造商
- 北美市場規模和預測（按國家）
- 北美市場規模和預測（按指標）
- 北美市場規模和預測（按疾病類型）
- 北美市場規模和預測（按年齡層）
- 美國
- 加拿大
歐洲
- 概述
- 歐洲輕度認知障礙主要製造商
- 歐洲市場規模和預測（按國家）
- 歐洲市場規模與預測（按指標）
- 歐洲市場規模與預測（按疾病類型）
- 歐洲市場規模和預測（按年齡層）
- 德國
- 義大利
- 英國
- 法國
- 俄羅斯
- 荷蘭
- 瑞典
- 波蘭
- 歐洲其他地區
亞太地區 (APAC)
- 概述
- 亞太地區輕度認知障礙主要製造商
- 亞太地區市場規模與預測（按國家）
- 亞太地區市場規模與預測（依指標）
- 亞太地區市場規模與預測（按疾病類型）
- 亞太地區市場規模與預測（依年齡層）
- 印度
- 中國
- 日本
- 韓國
- 澳洲
- 泰國
- 印尼
- 菲律賓
- 亞太地區其他地區
拉丁美洲
- 概述
- 拉丁美洲輕度認知障礙主要製造商
- 拉丁美洲市場規模與預測（按國家）
- 拉丁美洲市場規模與預測（按指標）
- 拉丁美洲市場規模與預測（按疾病類型）
- 拉丁美洲市場規模與預測（按年齡層）
- 巴西
- 墨西哥
- 阿根廷
- 哥倫比亞
- 拉丁美洲其他地區
中東和非洲
- 概述
- 中東和非洲輕度認知障礙主要製造商
- 中東和非洲市場規模及預測（按國家）
- 中東和非洲市場規模及預測（依指標）
- 中東和非洲市場規模及預測（按疾病類型）
- 中東和非洲市場規模及預測（按年齡層）
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 土耳其
- 阿爾及利亞
- 埃及
- MEA 的其餘部分

第 11 章：主要供應商分析 - 輕度認知障礙產業

競爭儀表板
公司簡介
- Eli Lilly and Company
- Biogen Inc.
- Roche Holding AG
- Axovant Gene Therapies Ltd.
- GE Healthcare
- Philips Healthcare
- Neurotrack Technologies
- Cogstate Ltd.
- Lumosity Inc.
- Alzheimer's Drug Discovery Foundation (ADDF)
- AstraZeneca
- Novartis International AG
- Takeda Pharmaceutical Company Limited
- Denali Therapeutics Inc.
- HappyNeuron
- Others

第 12 章：360 度分析師視角

第 13 章：附錄

研究方法
參考
縮寫
免責聲明
聯絡我們

簡介目錄圖表

Product Code: ANV3526

REPORT HIGHLIGHT

Mild Cognitive Impairment Market size was valued at USD 1,980.21 Million in 2023, expanding at a CAGR of 5.24% from 2024 to 2032.

Mild Cognitive Impairment (MCI) is a kind of disease characterized by noticeable changes in cognitive function that are greater than expected for a person's age but not severe enough to interfere significantly with daily life. People with MCI might experience difficulties with memory, language, thinking, or judgment that are noticeable to themselves or others.

Mild Cognitive Impairment Market- Market Dynamics

The growing older population and advancement in diagnostic methods are expected to propel market demand

The prevalence of MCI and other cognitive disorders increases as the population rises. The growing number of older fuels demand diagnostic tools, treatments, and management strategies. There is a greater awareness and understanding of MCI among healthcare providers and the public. Advances in diagnostic methods and increased educational efforts contribute to higher detection rates and subsequent demand for interventions.

Further, increased healthcare spending on cognitive health and related areas drives demand for MCI-related products and services. Governments and private sectors are investing in better care solutions for cognitive disorders. The rise of digital health technologies, such as cognitive training apps, telemedicine, and wearable devices, enhances the management and monitoring of MCI. Technology improves patient engagement and provides new avenues for treatment and research. The development of drugs aimed at managing symptoms or modifying the progression of MCI influences market dynamics. New therapeutic agents and clinical trials contribute to growth in the pharmaceutical sector.

Mild Cognitive Impairment Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 524% over the forecast period (2024-2032)

Based on Indication segmentation, the Alzheimer's disease (AD) segment was predicted to show maximum market share in the year 2023, owing to the increased prevalence of Alzheimer's disease.

Based on Disease Type segmentation, the amnestic segment was the leading Disease Type in 2023, due to high prevalence among older adults.

Based on Age Group segmentation, the geriatric segment was the leading Age Group in 2023, owing to the high need for treatment of Alzheimer's, vascular dementia, etc.

On the basis of region, North America was the leading revenue generator in 2023, mainly due to the high incidence of Alzheimer's disease.

Mild Cognitive Impairment Market- Segmentation Analysis:

The Global Mild Cognitive Impairment Market is segmented on the basis of Indication, Disease Type, Age Group, and Region.

The market is divided into five categories based on Indication: Alzheimer's Disease, Vascular Dementia, Lewy Body Dementia, Parkinson's Disease Dementia, and others. The Alzheimer's Disease Dementia segment dominates the market. Mild cognitive impairment is needed for dementia cure which is contributing to segment growth.

The market is divided into two categories based on Disease Type: amnestic MCI and non-amnestic MCI. The amnestic MCI segment is projected to hold the largest share of the market. Amnestic mild cognitive impairment indicates memory deficiency and is not so severe condition but is growing among old age people.

The market is divided into three categories based on Age Group: child, adult, and geriatric. The geriatric segment dominates the market and is expected to maintain its high dominance during the forecast period. Older age people suffering from Alzheimer's and having mild cognitive impairment issue are boosting segment demand.

Mild Cognitive Impairment Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America dominates the Mild Cognitive Impairment market. The U.S. has a large and growing elderly population, contributing to a high prevalence of MCI. There is significant investment in research and development, along with advanced healthcare infrastructure that supports early diagnosis and treatment. In Asia, Japan has a high proportion of elderly individuals and is a leader in research and development related to cognitive impairments. The country has well-established healthcare services for managing MCI.

Mild Cognitive Impairment Market- Competitive Landscape:

The Mild Cognitive Impairment market is moderately competitive. The companies in the market are involved in developing drugs and therapies aimed at managing MCI and related cognitive disorders. Companies like Biogen and Eli Lily are developing treatments for Alzheimer's disease and other neurodegenerative conditions that can overlap with MCI. Companies with strong research and development pipelines are crucial in advancing treatments and diagnostics. Innovation in biomarkers and drug development are key competitive factors.

Recent Developments:

In July 2022, La Roche received FDA approval for the Elecsys Amyloid Plasma panel in the treatment of Alzheimer's disease.

In 2022, Teva Pharmaceuticals launched a generic Revlimid capsule for mild cognitive impairment care.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MILD COGNITIVE IMPAIRMENT MARKET KEY PLAYERS

Eli Lilly and Company
Biogen Inc.
Roche Holding AG
Axovant Gene Therapies Ltd.
GE Healthcare
Philips Healthcare
Neurotrack Technologies
Cogstate Ltd.
Lumosity Inc.
Alzheimer's Drug Discovery Foundation (ADDF)
AstraZeneca
Novartis International AG
Takeda Pharmaceutical Company Limited
Denali Therapeutics Inc.
HappyNeuron
Others

GLOBAL MILD COGNITIVE IMPAIRMENT MARKET, BY INDICATION- MARKET ANALYSIS, 2019-2032

Alzheimer's Disease
Vascular Dementia
Lewy Body Dementia
Parkinson Disease Dementia
Others

GLOBAL MILD COGNITIVE IMPAIRMENT MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019-2032

Amnestic MCI
Non-amnestic MCI

GLOBAL MILD COGNITIVE IMPAIRMENT MARKET, BY AGE GROUP- MARKET ANALYSIS, 2019-2032

Child
Adult
Geriatric

GLOBAL MILD COGNITIVE IMPAIRMENT MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Mild Cognitive Impairment Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Mild Cognitive Impairment Market Snippet by Indication
- 2.1.2. Mild Cognitive Impairment Market Snippet by Disease Type
- 2.1.3. Mild Cognitive Impairment Market Snippet by Age Group
- 2.1.4. Mild Cognitive Impairment Market Snippet by Country
- 2.1.5. Mild Cognitive Impairment Market Snippet by Region
2.2. Competitive Insights

3. Mild Cognitive Impairment Key Market Trends

3.1. Mild Cognitive Impairment Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Mild Cognitive Impairment Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Mild Cognitive Impairment Market Opportunities
3.4. Mild Cognitive Impairment Market Future Trends

4. Mild Cognitive Impairment Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Mild Cognitive Impairment Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Mild Cognitive Impairment Market Landscape

6.1. Mild Cognitive Impairment Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Mild Cognitive Impairment Market - By Indication

7.1. Overview
- 7.1.1. Segment Share Analysis, By Indication, 2024 & 2032 (%)
- 7.1.2. Alzheimer's Disease Dementia
- 7.1.3. Vascular Dementia
- 7.1.4. Lewy Body Dementia
- 7.1.5. Parkinson Disease Dementia
- 7.1.6. Others

8. Mild Cognitive Impairment Market - By Disease Type

8.1. Overview
- 8.1.1. Segment Share Analysis, By Disease Type, 2024 & 2032 (%)
- 8.1.2. Amnestic MCI
- 8.1.3. Non-amnestic MCI

9. Mild Cognitive Impairment Market - By Age Group

9.1. Overview
- 9.1.1. Segment Share Analysis, By Age Group, 2024 & 2032 (%)
- 9.1.2. Child
- 9.1.3. Adult
- 9.1.4. Geriatric

10. Mild Cognitive Impairment Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Mild Cognitive Impairment Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Mild Cognitive Impairment Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Mild Cognitive Impairment Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Mild Cognitive Impairment Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Mild Cognitive Impairment Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Mild Cognitive Impairment Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. Eli Lilly and Company
- 11.2.2. Biogen Inc.
- 11.2.3. Roche Holding AG
- 11.2.4. Axovant Gene Therapies Ltd.
- 11.2.5. GE Healthcare
- 11.2.6. Philips Healthcare
- 11.2.7. Neurotrack Technologies
- 11.2.8. Cogstate Ltd.
- 11.2.9. Lumosity Inc.
- 11.2.10. Alzheimer's Drug Discovery Foundation (ADDF)
- 11.2.11. AstraZeneca
- 11.2.12. Novartis International AG
- 11.2.13. Takeda Pharmaceutical Company Limited
- 11.2.14. Denali Therapeutics Inc.
- 11.2.15. HappyNeuron
- 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us

簡介目錄圖表

List of Tables

TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Mild Cognitive Impairment Market: Indication Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Indication
TABLE Global Mild Cognitive Impairment Market, by Indication 2019-2032 (USD Million)
TABLE Mild Cognitive Impairment Market: Disease Type Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Disease Type
TABLE Global Mild Cognitive Impairment Market, by Disease Type 2019-2032 (USD Million)
TABLE Mild Cognitive Impairment Market: Age Group Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Age Group
TABLE Global Mild Cognitive Impairment Market, by Age Group 2019-2032 (USD Million)
TABLE Mild Cognitive Impairment Market: Regional snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Mild Cognitive Impairment Market, by Region 2019-2032 (USD Million)
TABLE North America Mild Cognitive Impairment Market, by Country, 2019-2032 (USD Million)
TABLE North America Mild Cognitive Impairment Market, by Indication, 2019-2032 (USD Million)
TABLE North America Mild Cognitive Impairment Market, by Disease Type, 2019-2032 (USD Million)
TABLE North America Mild Cognitive Impairment Market, by Age Group, 2019-2032 (USD Million)
TABLE Europe Mild Cognitive Impairment Market, by Country, 2019-2032 (USD Million)
TABLE Europe Mild Cognitive Impairment Market, by Indication, 2019-2032 (USD Million)
TABLE Europe Mild Cognitive Impairment Market, by Disease Type, 2019-2032 (USD Million)
TABLE Europe Mild Cognitive Impairment Market, by Age Group, 2019-2032 (USD Million)
TABLE Asia Pacific Mild Cognitive Impairment Market, by Country, 2019-2032 (USD Million)
TABLE Asia Pacific Mild Cognitive Impairment Market, by Indication, 2019-2032 (USD Million)
TABLE Asia Pacific Mild Cognitive Impairment Market, by Disease Type, 2019-2032 (USD Million)
TABLE Asia Pacific Mild Cognitive Impairment Market, by Age Group, 2019-2032 (USD Million)
TABLE Latin America Mild Cognitive Impairment Market, by Country, 2019-2032 (USD Million)
TABLE Latin America Mild Cognitive Impairment Market, by Indication, 2019-2032 (USD Million)
TABLE Latin America Mild Cognitive Impairment Market, by Disease Type, 2019-2032 (USD Million)
TABLE Latin America Mild Cognitive Impairment Market, by Age Group, 2019-2032 (USD Million)
TABLE Middle East and Africa Mild Cognitive Impairment Market, by Country, 2019-2032 (USD Million)
TABLE Middle East and Africa Mild Cognitive Impairment Market, by Indication, 2019-2032 (USD Million)
TABLE Middle East and Africa Mild Cognitive Impairment Market, by Disease Type, 2019-2032 (USD Million)
TABLE Middle East and Africa Mild Cognitive Impairment Market, by Age Group, 2019-2032 (USD Million)

List of Figures

FIGURE Mild Cognitive Impairment Market Segmentation
FIGURE Market research methodology
FIGURE Value chain analysis
FIGURE Porter's Five Forces Analysis
FIGURE Market Attractiveness Analysis
FIGURE COVID-19 Impact Analysis
FIGURE Pre & Post COVID-19 Impact Comparision Study
FIGURE Competitive Landscape; Key company market share analysis, 2023
FIGURE Indication segment market share analysis, 2023 & 2032
FIGURE Indication segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Disease Type segment market share analysis, 2023 & 2032
FIGURE Disease Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Age Group segment market share analysis, 2023 & 2032
FIGURE Age Group segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Regional segment market share analysis, 2023 & 2032
FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE North America Mild Cognitive Impairment Market share and leading players, 2023
FIGURE Europe Mild Cognitive Impairment Market share and leading players, 2023
FIGURE Asia Pacific Mild Cognitive Impairment Market share and leading players, 2023
FIGURE Latin America Mild Cognitive Impairment Market share and leading players, 2023
FIGURE Middle East and Africa Mild Cognitive Impairment Market share and leading players, 2023
FIGURE North America market share analysis by country, 2023
FIGURE U.S. Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Canada Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Europe Mild Cognitive Impairment Market share analysis by country, 2023
FIGURE Germany Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Spain Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Italy Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE France Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE UK Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Russia Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Netherlands Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Sweden Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Poland Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Rest of the Europe Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Asia Pacific Mild Cognitive Impairment Market share analysis by country, 2023
FIGURE India Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE China Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Japan Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE South Korea Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Australia Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Thailand Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Indonesia Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Philippines Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Rest of APAC Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Latin America Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Latin America Mild Cognitive Impairment Market share analysis by country, 2023
FIGURE Brazil Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Mexico Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Argentina Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Colombia Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Rest of LATAM Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Middle East and Africa Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Middle East and Africa Mild Cognitive Impairment Market share analysis by country, 2023
FIGURE Saudi Arabia Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE United Arab Emirates Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Israel Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Turkey Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Algeria Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Egypt Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Rest of MEA Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)